Large gap with delayed quotes
|
Last quote
03/17/2025 -
17:35:00
|
Bid
03/17/2025 -
19:19:44
|
Bid Volume |
Ask
03/17/2025 -
17:19:55
|
Ask Volume |
|---|---|---|---|---|
|
91.90
+1.75
(
+1.94% )
|
0.00
|
300 |
91.95
|
166 |
Analysis date: 14.03.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 11.03.2025.
Interest
Very strong
Very strong
Four stars since 11.03.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 07.03.2025 at a price of 99.44.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 07.03.2025.
4wk Rel Perf
-18.84%
-18.84%
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 18.84% behind the STOXX600.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 07.03.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.87%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.72%.
Mkt Cap in $bn
24.19
24.19
With a market capitalization >$8bn, GALDERMA GROUP is considered a large-cap stock.
G/PE Ratio
1.41
1.41
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
20
20
The estimated PE is for the year 2027.
LT Growth
27.98%
27.98%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
0.23%
0.23%
The twelve month estimated dividend yield represents 4.51% of earnings forecasts.
Beta
59
59
For 1% of index variation, the stock varies on average by 0.59%.
Correlation
0.19
0.19
Stock movements are totally independent of index variations.
Value at Risk
10.83
10.83
The value at risk is estimated at CHF 10.83. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
23.08.2024
23.08.2024